Ikuo Hirano

28.1k total citations · 9 hit papers
285 papers, 11.8k citations indexed

About

Ikuo Hirano is a scholar working on Surgery, Rheumatology and Gastroenterology. According to data from OpenAlex, Ikuo Hirano has authored 285 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 263 papers in Surgery, 117 papers in Rheumatology and 46 papers in Gastroenterology. Recurrent topics in Ikuo Hirano's work include Eosinophilic Esophagitis (247 papers), Eosinophilic Disorders and Syndromes (116 papers) and Esophageal and GI Pathology (48 papers). Ikuo Hirano is often cited by papers focused on Eosinophilic Esophagitis (247 papers), Eosinophilic Disorders and Syndromes (116 papers) and Esophageal and GI Pathology (48 papers). Ikuo Hirano collaborates with scholars based in United States, Switzerland and Netherlands. Ikuo Hirano's co-authors include Nirmala Gonsalves, Evan S. Dellon, Raj K. Goyal, John E. Pandolfino, Peter J. Kahrilas, Glenn T. Furuta, David A. Katzka, Chris A. Liacouras, Joel E. Richter and Bethany Doerfler and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Ikuo Hirano

271 papers receiving 11.6k citations

Hit Papers

ACG Clinical Guideline: E... 1996 2026 2006 2016 2013 2001 2012 1996 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ACG Clinical Guideline: Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE)
    2013 827 citations Evan S. Dellon, Nirmala Gonsalves et al. The American Journal of Gastroenterology profile →
  2. Long-term Outcome of Medical and Surgical Therapies for Gastroesophageal Reflux Disease
    2001 648 citations Ikuo Hirano et al. profile →
  3. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system
    2012 620 citations Ikuo Hirano, Nirmala Gonsalves et al. Gut profile →
  4. The Enteric Nervous System
    1996 568 citations Ikuo Hirano et al. New England Journal of Medicine profile →
  5. Epidemiology and Natural History of Eosinophilic Esophagitis
    2017 522 citations Evan S. Dellon, Ikuo Hirano Gastroenterology profile →
  6. Elimination Diet Effectively Treats Eosinophilic Esophagitis in Adults; Food Reintroduction Identifies Causative Factors
    2012 443 citations Nirmala Gonsalves, Guang‐Yu Yang et al. Gastroenterology profile →
  7. American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
    2017 411 citations Ikuo Hirano et al. Gastroenterology profile →
  8. Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis
    2024 34 citations Marc E. Rothenberg, Evan S. Dellon et al. New England Journal of Medicine profile →
  9. ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis
    2025 26 citations Evan S. Dellon, David A. Katzka et al. The American Journal of Gastroenterology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ikuo Hirano 10.0k 5.4k 3.3k 1.7k 819 285 11.8k
David A. Katzka 9.7k 1.0× 3.4k 0.6× 4.3k 1.3× 862 0.5× 571 0.7× 486 11.5k
J C Goligher 5.3k 0.5× 1.1k 0.2× 1.1k 0.3× 150 0.1× 1.6k 2.0× 172 7.8k
François Mion 4.7k 0.5× 928 0.2× 3.5k 1.1× 51 0.0× 478 0.6× 201 6.2k
Frank Zerbib 5.3k 0.5× 368 0.1× 4.6k 1.4× 146 0.1× 188 0.2× 153 6.4k
Ghislain Devroede 2.8k 0.3× 1.5k 0.3× 2.1k 0.6× 50 0.0× 612 0.7× 151 5.0k
Marc S. Levine 3.8k 0.4× 278 0.1× 1.6k 0.5× 60 0.0× 377 0.5× 280 5.4k
L. Hultén 2.5k 0.3× 842 0.2× 759 0.2× 89 0.1× 943 1.2× 146 4.3k
Atsuyuki Yamataka 4.4k 0.4× 548 0.1× 540 0.2× 110 0.1× 237 0.3× 464 5.2k
G Triolo 671 0.1× 2.3k 0.4× 75 0.0× 2.1k 1.3× 545 0.7× 209 5.7k
Marco A. Cimmino 955 0.1× 2.6k 0.5× 98 0.0× 355 0.2× 203 0.2× 173 5.1k

Countries citing papers authored by Ikuo Hirano

Since Specialization
Citations

This map shows the geographic impact of Ikuo Hirano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ikuo Hirano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ikuo Hirano more than expected).

Fields of papers citing papers by Ikuo Hirano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ikuo Hirano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ikuo Hirano. The network helps show where Ikuo Hirano may publish in the future.

Co-authorship network of co-authors of Ikuo Hirano

This figure shows the co-authorship network connecting the top 25 collaborators of Ikuo Hirano. A scholar is included among the top collaborators of Ikuo Hirano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ikuo Hirano. Ikuo Hirano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirano, Ikuo, Glenn T. Furuta, Gary W. Falk, et al.. (2025). Review article: Seeing Is Believing–The Eosinophilic Oesophagitis Endoscopic Reference Score Can Serve as a Valuable Clinical Trial Endpoint in Eosinophilic Oesophagitis. Alimentary Pharmacology & Therapeutics. 63(3). 341–351.
2.
Collins, Margaret H., Marc E. Rothenberg, Evan S. Dellon, et al.. (2025). Dupilumab Improves Histopathologic Features in Patients With Eosinophilic Esophagitis: LIBERTY EoE TREET Study Results. Gastro Hep Advances. 4(6). 100646–100646.
3.
4.
Rothenberg, Marc E., Evan S. Dellon, Margaret H. Collins, et al.. (2024). Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis. New England Journal of Medicine. 390(24). 2252–2263. 34 indexed citations breakdown →
5.
Ackerman, Steven J., Amir F. Kagalwalla, Zhaoxing Pan, et al.. (2024). The Minimally Invasive 1-Hour Esophageal String Test Monitors Therapeutic Changes in Mucosal Inflammation in Eosinophilic Esophagitis. The American Journal of Gastroenterology. 120(1). 254–258. 1 indexed citations
6.
7.
Carlson, Dustin A., Ikuo Hirano, Nirmala Gonsalves, et al.. (2023). A PhysioMechanical Model of Esophageal Function in Eosinophilic Esophagitis. Gastroenterology. 165(3). 552–563.e4. 27 indexed citations
8.
Kou, Wenjun, et al.. (2023). Measuring esophageal compliance using functional lumen imaging probe to assess remodeling in eosinophilic esophagitis. Neurogastroenterology & Motility. 35(4). e14525–e14525. 14 indexed citations
9.
Gonsalves, Nirmala, Bethany Doerfler, Angelika Zalewski, et al.. (2023). Prospective study of an amino acid–based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial. Journal of Allergy and Clinical Immunology. 152(3). 676–688. 19 indexed citations
10.
Kuang, Fei Li, Angelika Zalewski, Katie Amsden, et al.. (2023). Bulk T‐cell receptor sequencing confirms clonality in pediatric eosinophilic esophagitis and identifies a food‐specific repertoire. Allergy. 78(9). 2487–2496. 3 indexed citations
11.
Silverberg, Jonathan I., Mark Boguniewicz, Francisco J. Quintana, et al.. (2023). Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review. Journal of Allergy and Clinical Immunology. 154(1). 1–10. 44 indexed citations
12.
Rothenberg, Marc E., Evan S. Dellon, Margaret H. Collins, et al.. (2023). 610 EFFICACY AND SAFETY OF BENRALIZUMAB IN ADULTS AND ADOLESCENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 24-WEEK DOUBLE-BLIND PERIOD OF THE PHASE 3 MESSINA TRIAL. Gastroenterology. 164(6). S–114. 8 indexed citations
13.
Hirano, Ikuo & David A. Katzka. (2023). Comparing the relative efficacy of therapeutics for eosinophilic oesophagitis: is counting eosinophils the right target?. Gut. 72(11). 2007–2008. 1 indexed citations
14.
Lee, Jeffrey K., Stephanie Coward, Gilaad G. Kaplan, et al.. (2023). 465 EPIDEMIOLOGIC BURDEN AND PROJECTIONS FOR EOSINOPHILIC ESOPHAGITIS-ASSOCIATED EMERGENCY DEPARTMENT VISITS IN THE UNITED STATES (2009-2030). Gastroenterology. 164(6). S–89. 1 indexed citations
15.
Araujo, Isis K., Ikuo Hirano, Nirmala Gonsalves, et al.. (2023). 1220 THE SEVERITY OF REDUCED ESOPHAGEAL DISTENSIBILITY PARALLELS EOSINOPHILIC DISEASE DURATION. Gastroenterology. 164(6). S–249. 1 indexed citations
16.
Kato, Koichiro, Ikuo Hirano, Yotaro Matsumoto, et al.. (2023). Drugs activating hypoxia-inducible factors correct erythropoiesis and hepcidin levels via renal EPO induction in mice. Blood Advances. 7(15). 3793–3805. 10 indexed citations
17.
Limketkai, Berkeley N., Shailja C. Shah, Ikuo Hirano, Emanuelle Bellaguarda, & Jean‐Frédéric Colombel. (2019). Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis. Gut. 68(12). 2152–2160. 48 indexed citations
18.
Dellon, Evan S., David A. Katzka, Margaret H. Collins, et al.. (2017). Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis. Carolina Digital Repository (University of North Carolina at Chapel Hill). 1 indexed citations
19.
Prasad, Meena & Ikuo Hirano. (2013). Eosinophilic esophagitis: are we just scratching the surface?. PubMed Central. 2 indexed citations
20.
Zhang, Qing, et al.. (2008). Acid Reflux Detection and Symptom-Reflux Association Using 4-Day Wireless pH Recording Combining 48-Hour Periods Off and On PPI Therapy. The American Journal of Gastroenterology. 103(7). 1631–1637. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David A. Katzka Breakdown of academic impact, for papers by J C Goligher Breakdown of academic impact, for papers by François Mion Breakdown of academic impact, for papers by Frank Zerbib Breakdown of academic impact, for papers by Ghislain Devroede Breakdown of academic impact, for papers by Marc S. Levine Breakdown of academic impact, for papers by L. Hultén Breakdown of academic impact, for papers by Atsuyuki Yamataka Breakdown of academic impact, for papers by G Triolo Breakdown of academic impact, for papers by Marco A. Cimmino
Rankless by CCL
2026